Characteristics of Immunoglobulin Products Used to Treat Primary Immunodeficiencies is licensed for use in the United States. This guidebook is updated regularly to keep you up-to-date on any changes with a product.
Please note: this guide is an 18-page long PDF booklet. There is also this online chart of individual product information for those that prefer not to print the full document.
Last update: August 2022